ZA953206B - High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base - Google Patents

High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base

Info

Publication number
ZA953206B
ZA953206B ZA953206A ZA953206A ZA953206B ZA 953206 B ZA953206 B ZA 953206B ZA 953206 A ZA953206 A ZA 953206A ZA 953206 A ZA953206 A ZA 953206A ZA 953206 B ZA953206 B ZA 953206B
Authority
ZA
South Africa
Prior art keywords
cyclodextrin
base
inclusion complexes
high solubility
acidic drug
Prior art date
Application number
ZA953206A
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Maurizio Del Canale
Maurizio Redenti
Daniela Acerbi
Massimo Pasini
Josef Szettli
Maria Vikmon
Eva Fenyvesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA953206B publication Critical patent/ZA953206B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA953206A 1994-04-22 1995-04-20 High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base ZA953206B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940790A IT1269578B (it) 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.

Publications (1)

Publication Number Publication Date
ZA953206B true ZA953206B (en) 1996-01-03

Family

ID=11368715

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953206A ZA953206B (en) 1994-04-22 1995-04-20 High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base

Country Status (13)

Country Link
US (1) US5773029A (es)
EP (1) EP0756493B1 (es)
AT (1) ATE194777T1 (es)
AU (1) AU2307695A (es)
CA (1) CA2188388A1 (es)
DE (1) DE69518070T2 (es)
ES (1) ES2148512T3 (es)
HK (1) HK1013627A1 (es)
IL (1) IL113450A (es)
IT (1) IT1269578B (es)
PT (1) PT756493E (es)
WO (1) WO1995028965A1 (es)
ZA (1) ZA953206B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018245A1 (en) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complex of naproxen and beta-cyclodextrin
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
DK0811386T3 (da) * 1996-05-07 2005-01-03 Pfizer Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleks
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6939863B2 (en) 2002-01-04 2005-09-06 Wei-Jan Chen Prevention of atherosclerosis and restenosis
MXPA04009968A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
ES2286177T3 (es) * 2002-06-17 2007-12-01 Chiesi Farmaceutici S.P.A. Procedimiento para la preparacion de piroxicam: compuestos de inclusion de betaciclodextrina.
WO2004017897A2 (en) * 2002-08-20 2004-03-04 Bristol-Myers Squibb Company Aripiprazole complex formulation and method
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260872B4 (de) 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
US20070020578A1 (en) * 2005-07-19 2007-01-25 Scott Robert R Dental curing light having a short wavelength LED and a fluorescing lens for converting wavelength light to curing wavelengths and related method
WO2006034147A2 (en) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions and methods for the preparation and administration of poorly water soluble drugs
EP1954256A2 (en) * 2005-11-09 2008-08-13 Torrent Pharmaceuticals Ltd Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CA2763365C (en) 2009-05-29 2016-09-13 Cydex Pharmaceuticals, Inc. Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
CN108210501B (zh) 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
CN117320727A (zh) * 2021-03-04 2023-12-29 生物切萨皮克有限责任公司 低吸附格列本脲制剂及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
GR880100854A (el) * 1987-12-22 1994-03-31 Glaxo Group Ltd Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος.
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina

Also Published As

Publication number Publication date
DE69518070D1 (de) 2000-08-24
WO1995028965A1 (en) 1995-11-02
PT756493E (pt) 2000-10-31
ES2148512T3 (es) 2000-10-16
AU2307695A (en) 1995-11-16
US5773029A (en) 1998-06-30
DE69518070T2 (de) 2001-01-11
ITMI940790A1 (it) 1995-10-22
IL113450A (en) 1999-05-09
CA2188388A1 (en) 1995-11-02
EP0756493B1 (en) 2000-07-19
EP0756493A1 (en) 1997-02-05
IL113450A0 (en) 1995-07-31
ATE194777T1 (de) 2000-08-15
ITMI940790A0 (it) 1994-04-22
HK1013627A1 (en) 1999-09-03
IT1269578B (it) 1997-04-08

Similar Documents

Publication Publication Date Title
IL113450A0 (en) High solibility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
DK1036058T3 (da) Adamantanderivater
DE69808130T2 (de) Adamantan-derivate
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
DE69106714D1 (en) Hypoglykämische hydroxyharnstoffderivate.
MY125978A (en) Admantane derivatives
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
HK1025558A1 (en) Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
ZA962946B (en) Anellated beta-carbolines
HRPK921028B1 (en) Binder for heat-set colours
AU7054991A (en) 4-azatricyclo{2.2.1.02,6}heptanes and pharmaceutical compositions
NZ517348A (en) Use of a mycobacterial extract in the treatment of inflammatory bowel disease
ZA942972B (en) New quinoxalinedione derivatives, their production and use in pharmaceutical agents.